Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Discovery & Development Drug Discovery, COVID-19

Trial Ready

The University of Oxford receives its first batch of AZD1222, a coronavirus vaccine candidate.

| Quick Read

Academics at the Jenner Institute at the University of Oxford, UK, have received 4000
doses of AZD1222 (formerly known as ChAdOx1 nCoV-19) for use in a Phase 2/3
trial from Italian contract manufacturer Advent, part of the IRBM Group.

Find out more here 

Credit: Advent, IRBM

Enjoy our FREE content!

Log in or register to gain full unlimited access to all content on the The Medicine Maker site. It’s FREE!

Login

Forgot your password?

Or register now - it’s free!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

When you click “Register” we will email you a link, which you must click to verify the email address above and activate your account. If you do not receive this email, please contact us at [email protected].

Discovery & Development Drug Discovery, COVID-19

Related Webinars

Discovery & Development COVID-19

Post-Pandemic Planning: What Will Change in the Clinical Supply Chain?

| Sponsored by Thermo Fisher Scientific

Discovery & Development COVID-19

Post-Pandemic Planning: What Will Change in Early-Phase Drug Development?

| Sponsored by Thermo Fisher Scientific

Discovery & Development Clinical Trials

Double blind. Zero bias.

| Sponsored by Capsugel Lonza

Most Popular

1. Business & Regulation Business Practice

Crafting a Culture of Excellence

| Maryam Mahdi

2. Business & Regulation Business Practice

Stemming the Brain Drain

| Kelly Chibale

3. Business & Regulation Business Practice

Building a Beautiful Biotech

| James Strachan

4. Manufacture Formulation

The Rise of Lipid Nanoparticles

| Rahul Keswani, Benjamin King

5. Discovery & Development Drug Delivery

Melt in the Mouth

| Elizabeth Hickman

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

December Issue of The Medicine Maker